ABSTRACT Introduction: Cytochrome P450 (CYP) is a monooxygenase superfamily
mediating the elimination of anti-hypertensive drugs. Polymorphisms of CYP would lead to …

Background The clinical implementation of pharmacogenomics (PGx) has often involved
teams that include pharmacists. PGx laboratories often provide baseline information within …

Medicine gets personal and tailor‐made treatments are underway. Hospitals have started to
advertise their advanced genomic testing capabilities and even their disruptive technologies …

Abstract Objective The Genomic Medicine Working Group of the National Advisory Council
for Human Genome Research virtually hosted its 13th genomic medicine meeting titled …

Introduction: The purpose of this study is to assess the extent of the familiarity, attitude and
perceptions of dental professionals regarding clinical dental guidelines and their …

Pharmacogenomics (PGx) is the knowledge of diverse drug responses and effects in
people, based on their genomic profiles. Such information is considered as one of the main …

Background: Precision medicine represents an evolving approach to improve treatment
efficacy by modifying it to individual patient's gene variation. Pharmacogenetics, an …

The promise of treatments for common complex diseases (CCDs) is understood as an
important force driving large scale genetics research over the last few decades. This paper …

The majority of health professionals now have genetic and genomic competencies and
some are measured by certification standards. Nursing has a proud history of defining roles …

Pharmacogenomics clinical decision support (PGx-CDS) is an important tool to incorporate
PGx information into existing clinical workflows and facilitate PGx clinical translation …